Similar Stories 🔰

The rising incidence of liver cancer across the globe is becoming an alarming public health concern. Once considered relatively uncommon in many regions, liver cancer cases are now increasing steadily due to a combination of lifestyle factors, chroni

The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.

Oral cancer cases are rising among non-smokers, with more women being affected. Experts warn that factors like poor oral hygiene, HPV infection, and lifestyle changes are contributing, making early detection and regular screening crucial.

The researchers found that over the last 30 years, the rise in colorectal cancer deaths in young adults occurred almost entirely among people without a four-year college degree.

Dr Kunal Sood explains the science behind broccoli and broccoli sprouts, focusing on sulforaphane and its role in supporting the body's antioxidant and detox pathways. He clarifies that while beneficial, these foods are not a direct anti-cancer solution.

Broccoli sprouts is the new anti-cancer buzzword on social media, but does it actually prevent cancer? Dr Sood explains how it can lower the risk. | Health

Heavy lifting can increase the risk of hernia and may sometimes delay the diagnosis of serious conditions like cancer. Experts advise proper lifting techniques and early medical consultation if symptoms like lumps, pain, or swelling appear.

Keytruda, an immunotherapy drug, is transforming cancer treatment in India by helping the immune system fight cancer cells. Experts say it offers improved outcomes in several advanced cancers and marks a shift towards precision oncology.

A Rs1.5 lakh cancer drug meant to save lives is being leaked and counterfeited across India, exposing patients to fake treatments, financial loss, and dangerous delays in critical, life-saving care., Health, Times Now

In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.